NEW YORK, May 19 (Reuters) - Johnson & Johnson said six-month study data showed its new experimental stent was better than Boston Scientific's Taxus at preventing re-growth of tissue within the tiny ...

Johnson & Johnson intends to exit the drug-coated stent market by the end of this year-which could be good news for rivals like Fridley-based Medtronic, Inc., and Natick, Massachusetts-based Boston ...

CHICAGO, May 7 (Reuters) - Johnson & Johnson on Monday said its experimental drug-coated stent failed to meet its primary study goal, leading it to drop development of the heart device. J&J unit Conor ...

NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.

SAN FRANCISCO (MarketWatch) -- Boston Scientific Corp. and Johnson & Johnson after Thursday's closing bell said the U.S. District Court in Delaware has issued rulings on two previous jury decisions in ...

BARCELONA—A thermo-expandable segmental metallic stent has scored higher than a conventional polyurethane plastic stent on a validated quality of life questionnaire completed by patients with ureteral ...